VEW 2024: Making AI a friend of your practice, not foe

Commentary
Video

Easy Anayama offers tips and tricks for leveraging AI in your practice.

At Vision Expo West 2024 in Las Vegas, Nevada, Easy Anyama, a member of the AI panel on the Innovation Stage, provides insights and guidance on how to leverage AI in a way that benefits your practice. The primary goal is to demonstrate how AI can benefit optometry and dispel any fears or misconceptions about the technology.

Anyama introduces the topic, explaining that the discussion will cover practical solutions and industry expert perspectives on integrating AI into various aspects of optometry, from clinical care to administration. The focus is on helping optometrists understand how to effectively utilize AI tools and overcome any hesitation about adopting them. One of the key benefits Anyama highlights is the potential for improved communication, both with patients and other healthcare providers. AI tools can assist in personalizing patient education materials, such as translating them into different languages, to enhance understanding and engagement.

Sharing his own experience with AI, Anyama emphasizes the importance of managing expectations when it comes to AI. He advises optometrists to set clear goals, understand their workflows, and involve all relevant stakeholders before implementing any AI solutions. Maintaining realistic expectations and taking a measured, low-risk approach is crucial for successful integration.

Anyama also addresses the common misconception that AI is a monolithic entity, explaining that it encompasses various sub-sectors, each with its own pace of advancement. He argues that the fear surrounding AI is often fueled by marketing hype, rather than the actual capabilities of the technology. The real concern, he suggests, should be the risk of falling behind if optometrists fail to adopt AI tools, as other industry players may gain a competitive advantage.

To help optometrists navigate the AI landscape, Anyama outlines some common pitfalls to avoid, such as using private information in public chatbots or blindly trusting AI-generated outputs. He emphasizes the importance of finding tools specifically designed for eye care and aligning them with the practice's unique workflows.

In conclusion, Anyama encourages optometrists to embrace AI, take small, low-risk steps, and explore the potential benefits it can bring to their practice and patient care. He believes that with the right approach and understanding, AI can be a powerful tool that can significantly enhance the optometry profession.

Recent Videos
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
© 2024 MJH Life Sciences

All rights reserved.